FIELD: medicine.
SUBSTANCE: application of vinpocetine is proposed for treatment of changes of retro-cochlear origin, related with epilepsy, characterised by inhibiting changes of amplitudes and latencies of late waves of hearing answer of brainstem (HAB), which accompany convulsions and for treatment of loss of hearing, characterised by inhibiting of hearing threshold increase, induced during convulsions.
EFFECT: vinpocetine inhibits all changes of HAB waves, which accompany cortical epileptic activity during ictal and post-ictal periods, also inhibits evident loss of hearing and changes of characteristics on EEG, induced by two convulsive agents, which differ by their mechanism of acting.
4 cl, 7 dwg, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF ONE OR COMBINATION OF PHYTOCANNABINOIDS FOR TREATMENT OF EPILEPSY | 2010 |
|
RU2563143C2 |
| USE OF CARBAMATE DERIVATIVE FOR PREVENTION, RELIEF, OR TREATMENT OF MINOR EPILEPTIC SEIZURE OR EPILEPSY SHOWING MINOR EPILEPTIC SEIZURE | 2018 |
|
RU2787771C2 |
| 4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
| METHOD OF DETERMINING PECULIARITIES OF EPILEPSIA COURSE BASING ON PHYSIOLOGICAL INDICATORS BY METHOD OF LOGIT-REGRESSION ANALYSIS | 2016 |
|
RU2637297C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
| SUBSTITUTED TRIA-AZOLES AND METHODS RELATING THERETO | 2016 |
|
RU2718049C2 |
| EPILEPSY DIAGNOSTICS METHOD BASED ON SET OF ELECTROENCEPHALOGRAPHIC INDICATORS, CHARACTERISTICS OF EXOGENOUS AND COGNITIVE EVOKED POTENTIALS, MOTOR AND AUTONOMIC PROVISION ACTIVITIES USING ARTIFICIAL NEURAL NETWORKS TECHNOLOGY | 2016 |
|
RU2637300C1 |
| METHOD OF CHILDREN ABSENTIA TREATMENT ASSOCIATED WITH IDIOPATHIC GENERALISED EPILEPSY | 2005 |
|
RU2329761C2 |
| THERAPEUTIC USE OF COMPOUNDS | 2011 |
|
RU2806629C2 |
| THERAPEUTIC APPLICATION OF COMPOUNDS | 2011 |
|
RU2640596C2 |
